|
시장보고서
상품코드
2126687
철 수크로스 시장 : 용도별, 최종사용자별, 유통 채널별, 지역별Iron Sucrose Market, By Application, By End User, By Distribution Channel, By Geography |
||||||
철 수크로스 시장은 2026년에 4억 1,970만 달러 규모가 될 것으로 추정되며, 2033년까지 7억 9,640만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 9.6%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 4억 1,970만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 9.60% | 2033년 시장 규모 예측: | 7억 9,640만 달러 |
철 수크로스는 널리 사용되는 정맥 주사용 철 제제로, 만성 신장질환(CKD) 환자, 혈액투석을 받고 있는 환자, 그리고 경구용 철제 요법에 내성이 있거나 반응이 없는 환자의 철 결핍성 빈혈(IDA) 치료에 권장됩니다. 철 수크로스에 포함된 다핵 철(III) 수산화물·수크로스 복합체는 원소 철의 서서히 방출에 적합하며, 철분의 신속한 보충과 적혈구 생성을 촉진합니다.
시장 동향
세계 철-수크로스 시장은 철결핍성 빈혈 유병률의 증가, 만성 신장질환 및 투석 환자에서의 정맥내 철 요법 이용 확대, 그리고 임상 현장에서 비경구용 철 제제에 대한 수용도 향상으로 인해 성장하고 있습니다. 철 수크로스 시장의 성장을 뒷받침하는 주요 요인으로는 개발도상국에서의 의료 접근성 개선, 제네릭 제제에 대한 유리한 규제 경로, 그리고 적절한 환자 집단에서 정맥내 철분 요법을 권장하는 임상 지침 등이 있습니다.
그러나 시장에는 과민증이나 철분 과다증의 위험, 감독 하에 투여해야 한다는 점, 그리고 고용량 또는 단일 투여가 가능한 새로운 정맥내 철분 제제와의 경쟁 등 몇 가지 제약이 존재합니다. 그럼에도 불구하고, 아시아태평양, 특히 중국과 인도에서 만성 신장질환의 유병률 증가와 의료 서비스 접근성 향상은 철-스크로오스 시장의 성장에 유망한 기회를 제공할 것입니다. 또한, 수술 전후 빈혈 및 심부전에 수반되는 철 결핍에 대한 연구가 증가함에 따라 철-스크로오스의 치료 용도가 확대될 가능성이 있습니다.
본 조사의 주요 특징
- 본 보고서는 다양한 부문에 걸친 잠재적 수익 기회를 규명하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장의 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음 매개변수(기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략)를 바탕으로 세계 철분-스크로오스 시장의 주요 기업 개요를 소개합니다.
- 본 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 본 ‘세계 철 수크로스 시장 보고서’는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 세계 철 수크로스 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 철 수크로스 시장 : 용도별, 2021-2033년
제5장 세계의 철 수크로스 시장 : 최종사용자별, 2021-2033년
제6장 세계의 철 수크로스 시장 : 유통 채널별, 2021-2033년
제7장 세계의 철 수크로스 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고문헌 및 조사 방법
KSM 26.09.09Iron Sucrose Market is estimated to be valued at USD 419.7 Mn in 2026 and is expected to reach USD 796.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 419.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.60% | 2033 Value Projection: | USD 796.4 Mn |
Iron sucrose is an intravenous iron formulation that is widely used and is recommended for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD), patients on hemodialysis, and patients who are intolerant or have non-responsiveness to oral iron therapy. The polynuclear iron (III)-hydroxide sucrose complex in iron sucrose is suitable for controlled release of elemental iron and helps to replenish iron rapidly and erythropoiesis.
Market Dynamics
The global iron sucrose market is driven by increasing prevalence of iron deficiency anemia, increasing use of intravenous iron therapy in chronic kidney disease and dialysis patients, and increasing acceptance of parenteral iron in clinical practice. Some of the key driving factors for the growth of the iron sucrose market are improving access to healthcare in developing economies, favorable regulatory pathway for generic formulations, and clinical guidelines recommending intravenous iron in appropriate patient populations.
However, a number of constraints are present in the market, such as risk of hypersensitivity, iron overload, and need for supervised administration, and competition from newer formulations of intravenous iron with high-dose or single-infusion treatment. Nevertheless, increasing prevalence of chronic kidney disease and access to healthcare in the Asia-Pacific region, especially in China and India, will offer lucrative opportunities for the growth of the iron sucrose market. In addition, increasing research in the area of perioperative anemia and iron deficiency associated with heart failure may drive the therapeutic use of iron sucrose.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global iron sucrose market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include CSL Limited, Fresenius Kabi AG, Viatris Inc., Hikma Pharmaceuticals PLC, Sandoz, Dr. Reddy's Laboratories Limited, Lupin Limited, Emcure Pharmaceuticals Limited, Gland Pharma Limited, and Zydus Lifesciences Limited
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global iron sucrose market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global iron sucrose market
Market Segmentation
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Chronic Kidney Disease
- Non-Chronic Kidney Disease
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Dialysis Centers
- Specialty Clinics
- Others
- Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- CSL Limited
- Fresenius Kabi AG
- Viatris Inc.
- Hikma Pharmaceuticals PLC
- Sandoz
- Reddy's Laboratories Limited
- Lupin Limited
- Emcure Pharmaceuticals Limited
- Gland Pharma Limited
- Zydus Lifesciences Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Iron Sucrose Market, By Application
- Global Iron Sucrose Market, By End User
- Global Iron Sucrose Market, By Distribution Channel
- Global Iron Sucrose Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Iron Sucrose Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Chronic Kidney Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Non-Chronic Kidney Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Iron Sucrose Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Dialysis Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Iron Sucrose Market, By Distribution Channel, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Iron Sucrose Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Company Profile
- CSL Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sandoz
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reddy's Laboratories Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lupin Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Emcure Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gland Pharma Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zydus Lifesciences Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CSL Limited
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
